These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35720324)

  • 1. Case Report: New-Onset Rheumatoid Arthritis Following COVID-19 Vaccination.
    Watanabe T; Minaga K; Hara A; Yoshikawa T; Kamata K; Kudo M
    Front Immunol; 2022; 13():859926. PubMed ID: 35720324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis.
    Farroni C; Picchianti-Diamanti A; Aiello A; Nicastri E; Laganà B; Agrati C; Castilletti C; Meschi S; Colavita F; Cuzzi G; Casetti R; Grassi G; Petrone L; Vanini V; Salmi A; Repele F; Altera AMG; Maffongelli G; Corpolongo A; Salemi S; Di Rosa R; Nalli G; Sesti G; Vaia F; Puro V; Goletti D
    Front Immunol; 2022; 13():846753. PubMed ID: 35309297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New-onset Seropositive Rheumatoid Arthritis Following COVID-19 Vaccination in a Patient with Seronegative Status.
    Yonezawa H; Ohmura SI; Ohkubo Y; Miyamoto T
    Intern Med; 2022 Nov; 61(22):3449-3452. PubMed ID: 36070943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases.
    Larionova R; Byvaltsev K; Kravtsova О; Takha E; Petrov S; Kazarian G; Valeeva A; Shuralev E; Mukminov M; Renaudineau Y; Arleevskaya M
    J Transl Autoimmun; 2022; 5():100154. PubMed ID: 35434592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients.
    Picchianti-Diamanti A; Aiello A; Laganà B; Agrati C; Castilletti C; Meschi S; Farroni C; Lapa D; Najafi Fard S; Cuzzi G; Cimini E; Grassi G; Vanini V; Di Rosa R; Salemi S; Nalli G; Salmi A; Repele F; Altera AMG; Maffongelli G; Palazzolo C; Vita S; Leone S; Puro V; Capobianchi MR; Ippolito G; Nicastri E; Goletti D
    Front Immunol; 2021; 12():740249. PubMed ID: 34594343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked increase of interferon-β after BNT162b2 mRNA vaccination: a case of polyarthritis with pleurisy.
    Shimagami H; Yamaguchi Y; Kato Y; Kumanogoh A
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35236680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of humoral and cellular immune responses to a DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in normal rats.
    Xiao Z; Juan L; Song Y; Zhijian Z; Jing J; Kun Y; Yuna H; Dongfa D; Lili D; Liuxin T; Fei L; Nan L; Fang Y; Yuying S; Yongzhi X
    Hum Vaccin Immunother; 2015; 11(4):938-45. PubMed ID: 25763999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New-onset autoimmune phenomena post-COVID-19 vaccination.
    Chen Y; Xu Z; Wang P; Li XM; Shuai ZW; Ye DQ; Pan HF
    Immunology; 2022 Apr; 165(4):386-401. PubMed ID: 34957554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses.
    Saleem B; Ross RL; Bissell LA; Aslam A; Mankia K; Duquenne L; Corsadden D; Carter C; Hughes P; Nadat FA; Mulipa P; Lobb M; Clarke B; Mbara K; Morton R; Dibb S; Chowdhury R; Newton D; Pike A; Kakkar V; Savic S; DelGaldo F; Emery P
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35365569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression from palindromic rheumatism to rheumatoid arthritis after COVID-19 vaccination.
    Bansal P; Sonani B; Aslam F
    ARP Rheumatol; 2022; 1(1):100-101. PubMed ID: 35633584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Treatment of SARS-CoV-2 Vaccination-related Activation of Rheumatoid Arthritis with Positive Findings for Epstein-Barr Virus.
    Nakamura H; Nagasawa Y; Kobayashi H; Tsukamoto M; Takayama T; Kitamura N
    Intern Med; 2022 Jul; 61(13):2073-2076. PubMed ID: 35466171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative expression and correlation of tumor necrosis factor-α, interferon-γ, and interleukin-17 in the rheumatoid synovium.
    Nakajima A; Aoki Y; Sonobe M; Watanabe F; Takahashi H; Saito M; Nakagawa K
    Clin Rheumatol; 2016 Jul; 35(7):1691-7. PubMed ID: 27038187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients - A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease.
    Wagner A; Garner-Spitzer E; Schötta AM; Orola M; Wessely A; Zwazl I; Ohradanova-Repic A; Weseslindtner L; Tajti G; Gebetsberger L; Kratzer B; Tomosel E; Kutschera M; Tobudic S; Pickl WF; Kundi M; Stockinger H; Novacek G; Reinisch W; Zielinski C; Wiedermann U
    Front Immunol; 2022; 13():889138. PubMed ID: 35634285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity?
    Kang SH; Kim MY; Cho MY; Baik SK
    J Korean Med Sci; 2022 Apr; 37(15):e116. PubMed ID: 35437965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune inflammatory rheumatic diseases post-COVID-19 vaccination.
    Safary A; Esalatmanesh K; Eftekharsadat AT; Jafari Nakjavani MR; Khabbazi A
    Int Immunopharmacol; 2022 Sep; 110():109061. PubMed ID: 35978510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients.
    Bergamaschi C; Terpos E; Rosati M; Angel M; Bear J; Stellas D; Karaliota S; Apostolakou F; Bagratuni T; Patseas D; Gumeni S; Trougakos IP; Dimopoulos MA; Felber BK; Pavlakis GN
    Cell Rep; 2021 Aug; 36(6):109504. PubMed ID: 34352226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seropositive rheumatoid arthritis after vaccination against SARS-CoV-2 infection.
    Baimukhamedov C; Makhmudov S; Botabekova A
    Int J Rheum Dis; 2021 Nov; 24(11):1440-1441. PubMed ID: 34585843
    [No Abstract]   [Full Text] [Related]  

  • 19. Case Report: Acquired Haemophilia A Following mRNA-1273 Booster Vaccination Against SARS-CoV-2 With Concurrent Diagnosis of Pleomorphic Dermal Sarcoma.
    Plüß M; Mitteldorf C; Szuszies CJ; Tampe B
    Front Immunol; 2022; 13():868133. PubMed ID: 35479071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Bartels LE; Ammitzbøll C; Andersen JB; Vils SR; Mistegaard CE; Johannsen AD; Hermansen MF; Thomsen MK; Erikstrup C; Hauge EM; Troldborg A
    Rheumatol Int; 2021 Nov; 41(11):1925-1931. PubMed ID: 34476603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.